News

Pel-Freez at the Vaccine Innovation Forum in Shanghai

The Pel-Freez team had a busy and productive first day at the Vaccine Innovation Forum (VIF) in Shanghai. Our CTO, Dr. Chris Lyle, spent the day explaining the preparation and use of our complement products for bactericidal assays to vaccine developers attending the forum.

Pel-Freez supplies baby rabbit complement, antibody-depleted human complement, and negative-matrix serum to vaccine programs worldwide. If you missed us in Shanghai, contact us to talk about your assay needs.

Originally shared on LinkedIn by Attilio Baldassi, Director of Business Development.